Johanna W. Wilmink

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 203 publications

Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study.

Treatment considerations in patients with metastatic pancreatic cancer who did not receive systemic therapy: A population-based study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 18, 2026

The impact of lower household income and distance to hospital on treatment and survival in patients with localized pancreatic adenocarcinoma.

The impact of lower household income and distance to hospital on treatment and survival in patients with localized pancreatic adenocarcinoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: April 03, 2026

Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical Trial.

Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical Trial.

Journal: JAMA network open

Published: March 31, 2026

Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemotherapy in pancreatic cancer.

Preference versus protocol: oncology clinicians' perspectives on central venous access for administration of chemotherapy in pancreatic cancer.

Journal: ESMO gastrointestinal oncology

Published: March 11, 2026

Surgical outcomes from nationwide implementation of the international best practice for locally advanced pancreatic cancer (PREOPANC-4) study.

Surgical outcomes from nationwide implementation of the international best practice for locally advanced pancreatic cancer (PREOPANC-4) study.

Journal: The British journal of surgery

Published: February 28, 2026

Surgical Outcomes from Nationwide Implementation of the International Best-Practice for Locally Advanced Pancreatic Cancer (PREOPANC-4) study.

Surgical Outcomes from Nationwide Implementation of the International Best-Practice for Locally Advanced Pancreatic Cancer (PREOPANC-4) study.

Journal: The British journal of surgery

Published: February 28, 2026

The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer: A nationwide analysis.

The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer: A nationwide analysis.

Journal: European journal of cancer (Oxford, England : 1990)

Published: February 24, 2026

Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial.

Thromboembolic Events During Perioperative Therapy for Resectable and Borderline Resectable Pancreatic Cancer in the PREOPANC-2 Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 29, 2026

The Value of Stereotactic Radiotherapy After FOLFIRINOX in Patients with Pancreatic Cancer with Vascular Contact-A Nationwide, Retrospective Cohort Study.

The Value of Stereotactic Radiotherapy After FOLFIRINOX in Patients with Pancreatic Cancer with Vascular Contact-A Nationwide, Retrospective Cohort Study.

Journal: Cancers

Published: January 21, 2026

Second-line liposomal irinotecan plus S-1 vs. liposomal irinotecan plus 5-fluorouracil in metastatic pancreatic cancer: The phase I/II randomized NAPAN trial.

Second-line liposomal irinotecan plus S-1 vs. liposomal irinotecan plus 5-fluorouracil in metastatic pancreatic cancer: The phase I/II randomized NAPAN trial.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 12, 2025

The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer - Authors' reply.

The PREOPANC-2 trial in resectable and borderline resectable pancreatic cancer - Authors' reply.

Journal: The Lancet. Oncology

Published: December 01, 2025

Comparing short- and long-term survivors in metastatic pancreatic cancer: Insights into patient and disease profiles impacting systemic therapy outcomes.

Comparing short- and long-term survivors in metastatic pancreatic cancer: Insights into patient and disease profiles impacting systemic therapy outcomes.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 25, 2025

Showing 1-12 of 203

Last Updated: 09/26/2026